Cite
HARVARD Citation
Aki, A. et al. (2020). Anti‐ORAI1 antibody DS‐2741a, a specific CRAC channel blocker, shows ideal therapeutic profiles for allergic disease via suppression of aberrant T‐cell and mast cell activation. FASEB bioAdvances. 2 (8), pp. 478-488. [Online].